FIAPro™ Infectious Disease Detection Platform

Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.

A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.

CE-marked fluorescence immunoassay (FIA) analyzer for quantitative point-of-care testing. The MF-T1000 platform delivers rapid diagnostic results with 92.9%+ sensitivity, supporting respiratory combo tests (4-in-1/9-in-1 configurations) for clinical laboratories and healthcare facilities.

Automated platform for molecular diagnostics of infectious pathogens. Integrates nucleic acid extraction and amplification for rapid disease identification.

Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.

An indirect immunofluorescence technology platform for serological testing and antibody detection. The system is utilized for diagnosis of autoimmune and infectious diseases through fluorescence-based immunoassay methodology.

An immunolayer chromatography technology platform utilizing fluorescence detection for rapid diagnostic testing. Provides high sensitivity across multiple analyte categories including thyroid markers.

A fluorescence-based immunoassay platform from the POCT series designed for rapid diagnostic testing. The SF-100 platform enables high-sensitivity and high-precision immunofluorescence detection for various clinical analytes and sample types.

A point-of-care diagnostic platform supporting manual to high-throughput ELISA testing with easy automation capabilities. Enables laboratory-accurate results at the point-of-care.

An easy-to-operate platform that supports whole blood direct testing with results available in as fast as 3 minutes. It offers high detection throughput of up to 450 tests per hour, includes a built-in thermal printer, and features dedicated tuberculosis detection functionality to provide efficient and reliable testing solutions for primary healthcare settings.

A diagnostic platform utilizing two-way lateral flow technology for point-of-care testing. It provides rapid detection capabilities with precise temperature control, diverse connectivity options, and automatic sample recognition for efficient clinical diagnostics.

An innovative molecular detection platform utilizing microfluidic PCR technology capable of completing nucleic acid rapid detection within 30 minutes with high sensitivity and high specificity. The reagents are stable at room temperature without requiring cold chain storage, support customized multiplex detection, and can simultaneously detect up to 48 targets, providing an efficient solution for multi-pathogen detection.